Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus.

Dietary sodium restriction has a variety of effects on metabolism, including activation of the renin-angiotensin system. Angiotensin II has complex metabolic and cardiovascular effects, and these may be relevant to the effects of both nonpharmacological and pharmacological interventions in noninsulin-dependent diabetes mellitus (NIDDM). We have assessed the effect of dietary sodium restriction on insulin sensitivity and endogenous glucose production in eight normotensive patients with diet-controlled NIDDM who underwent hyperinsulinemic clamp studies in a randomized, double-blind, placebo-controlled cross-over protocol after two 4-day periods on sodium replete (160 mmol/day) and sodium deplete (40 mmol/day) diets. Mean +/- SD 24-h urinary sodium was 197 +/- 76.0 mmol (replete) and 67 +/- 19.5 mmol (deplete), P = 0.03. Insulin sensitivity was 42.0 +/- 11.3 mumol/kg.min (replete) and 37.0 +/- 11.6 mumol/kg.min (deplete), P = 0.04 (a reduction of 12%). Blood pressure was 130 +/- 21/78 +/- 11 mmHg (replete) and 128 +/- 12/73 +/- 10 mmHg (deplete). Dietary sodium restriction may result in a decrease in peripheral insulin sensitivity in normotensive patients with NIDDM, possibly via an elevation in prevailing angiotensin II concentrations.

[1]  D. Fliser,et al.  Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset , 1997, Journal of hypertension.

[2]  P. Meredith,et al.  Haemodynamic and hormonal responses to oral enalapril in salt depleted normotensive man. , 1993, British journal of clinical pharmacology.

[3]  Michael Somogyi,et al.  Determination of blood sugar. , 1945 .

[4]  H. Yki-Järvinen,et al.  Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. , 1995, Metabolism: clinical and experimental.

[5]  K. Jauch,et al.  Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience. , 1986, Postgraduate medical journal.

[6]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[7]  D. Simonson,et al.  Effect of sodium intake on insulin sensitivity. , 1993, The American journal of physiology.

[8]  J. Wikstrand,et al.  Low-dose angiotensin II increases glucose disposal rate during euglycemic hyperinsulinemia. , 1993, American journal of hypertension.

[9]  T. Buchanan,et al.  Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. , 1993, The Journal of clinical investigation.

[10]  R N Bergman,et al.  Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. , 1987, The Journal of clinical investigation.

[11]  N. Kneer,et al.  Regulation of gluconeogenesis by norepinephrine, vasopressin, and angiotensin II: a comparative study in the absence and presence of extracellular Ca2+1. , 1983, Archives of biochemistry and biophysics.

[12]  D. Adams,et al.  Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. , 1974, The Journal of clinical investigation.

[13]  P C Sternweis,et al.  Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. , 1991, Science.

[14]  R. Steele,et al.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.

[15]  D. Fliser,et al.  The effect of dietary salt on insulin sensitivity , 1995, European journal of clinical investigation.

[16]  D. Webb,et al.  Measurement of plasma angiotensin II. , 1985, Clinical science.

[17]  R. Steele,et al.  ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE. , 1963, Recent progress in hormone research.

[18]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[19]  A. Rocchini,et al.  Hyperinsulinemia and the Aldosterone and Pressor Responses to Angiotensin II , 1990, Hypertension.

[20]  J. Putney,et al.  Stimulation of glycogenolysis in hepatocytes by angiotensin II may involve both calcium release and calcium influx , 1983, FEBS letters.

[21]  R. Donnely,et al.  Clinical review 79: Angiotensin II: an insulin-sensitizing vasoactive hormone? , 1996, The Journal of clinical endocrinology and metabolism.

[22]  A. Salvetti,et al.  Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. , 1995, HYPERTENSION.

[23]  N. Silvis.  Nutritional recommendations for individuals with diabetes mellitus. , 1992, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[24]  C. Berne,et al.  A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. , 1989, The New England journal of medicine.

[25]  C. Kahn,et al.  Cross-talk between the insulin and angiotensin signaling systems. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Connell,et al.  Pressor and Subpressor Doses of Angiotensin II Increase Insulin Sensitivity in NIDDM: Dissociation of Metabolic and Blood Pressure Effects , 1994, Diabetes.

[27]  A. Distler,et al.  Insulin resistance in young salt-sensitive normotensive subjects. , 1993, Hypertension.

[28]  A. Grey,et al.  Moderate dietary salt restriction does not alter insulin resistance or serum lipids in normal men. , 1996, American journal of hypertension.

[29]  B. Dawson-Hughes,et al.  Plasma angiotensin II concentration regulates vascular but not adrenal responsiveness to restriction of sodium intake in normal man. , 1981, Clinical science.

[30]  R. DeFronzo,et al.  Epinephrine-induced insulin resistance in man. , 1980, The Journal of clinical investigation.